Rtw Investments as of Sept. 30, 2025
Portfolio Holdings for Rtw Investments
Rtw Investments holds 74 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Madrigal Pharmaceuticals (MDGL) | 11.3 | $914M | 2.0M | 458.66 | |
| Argenx Se Sponsored Adr (ARGX) | 6.1 | $497M | 674k | 737.56 | |
| Avidity Biosciences Ord (RNA) | 6.1 | $496M | 11M | 43.57 | |
| Ptc Therapeutics I (PTCT) | 5.9 | $475M | 7.7M | 61.37 | |
| Insmed Com Par $.01 (INSM) | 5.5 | $444M | 3.1M | 144.01 | |
| Protagonist Therapeutics (PTGX) | 4.7 | $382M | 5.8M | 66.43 | |
| Natera (NTRA) | 4.0 | $322M | 2.0M | 160.97 | |
| Akero Therapeutics (AKRO) | 3.2 | $260M | 5.5M | 47.48 | |
| Uniqure Nv SHS (QURE) | 3.2 | $258M | 4.4M | 58.37 | |
| Penumbra (PEN) | 2.7 | $220M | 867k | 253.32 | |
| RadNet (RDNT) | 2.6 | $215M | 2.8M | 76.21 | |
| Merus N V (MRUS) | 2.3 | $191M | 2.0M | 94.15 | |
| Tarsus Pharmaceuticals (TARS) | 2.3 | $189M | 3.2M | 59.43 | |
| Stryker Corporation (SYK) | 2.2 | $181M | 490k | 369.67 | |
| Immunocore Hldgs Ads (IMCR) | 2.2 | $177M | 4.9M | 36.33 | |
| ACADIA Pharmaceuticals (ACAD) | 1.9 | $153M | 7.1M | 21.34 | |
| Cytokinetics Com New (CYTK) | 1.8 | $150M | 2.7M | 54.96 | |
| Neurocrine Biosciences (NBIX) | 1.8 | $149M | 1.1M | 140.38 | |
| Axsome Therapeutics (AXSM) | 1.7 | $136M | 1.1M | 121.45 | |
| Stoke Therapeutics (STOK) | 1.5 | $120M | 5.1M | 23.50 | |
| Apogee Therapeutics (APGE) | 1.3 | $108M | 2.7M | 39.73 | |
| Establishment Labs Holdings Ord (ESTA) | 1.3 | $106M | 2.6M | 40.99 | |
| Masimo Corporation (MASI) | 1.2 | $101M | 683k | 147.55 | |
| Ultragenyx Pharmaceutical (RARE) | 1.2 | $98M | 3.3M | 30.08 | |
| Guardant Health (GH) | 1.1 | $93M | 1.5M | 62.48 | |
| Urogen Pharma (URGN) | 1.1 | $91M | 4.5M | 19.95 | |
| Intuitive Surgical Com New (ISRG) | 1.1 | $91M | 203k | 447.23 | |
| Gh Research Ordinary Shares (GHRS) | 1.0 | $80M | 5.6M | 14.30 | |
| Taysha Gene Therapies Com Shs (TSHA) | 1.0 | $80M | 24M | 3.27 | |
| Zai Lab Adr (ZLAB) | 1.0 | $78M | 2.3M | 33.89 | |
| Immatics SHS (IMTX) | 0.9 | $75M | 8.8M | 8.52 | |
| Xencor (XNCR) | 0.9 | $73M | 6.2M | 11.73 | |
| Cg Oncology (CGON) | 0.8 | $69M | 1.7M | 40.28 | |
| Beta Bionics (BBNX) | 0.8 | $66M | 3.3M | 19.87 | |
| Spyre Therapeutics Com New (SYRE) | 0.7 | $61M | 3.6M | 16.76 | |
| Rocket Pharmaceuticals (RCKT) | 0.7 | $58M | 18M | 3.26 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.7 | $56M | 2.3M | 24.25 | |
| Alkermes SHS (ALKS) | 0.6 | $50M | 1.7M | 30.00 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.6 | $50M | 8.7M | 5.73 | |
| Cogent Biosciences (COGT) | 0.6 | $50M | 3.5M | 14.36 | |
| Verastem Com New (VSTM) | 0.6 | $48M | 5.4M | 8.83 | |
| Quest Diagnostics Incorporated (DGX) | 0.6 | $48M | 250k | 190.58 | |
| Lenz Therapeutics (LENZ) | 0.5 | $40M | 863k | 46.58 | |
| Rapt Therapeutics Com New (RAPT) | 0.5 | $38M | 1.5M | 25.79 | |
| Oruka Therapeutics (ORKA) | 0.5 | $37M | 1.9M | 19.23 | |
| Dyne Therapeutics (DYN) | 0.5 | $37M | 2.9M | 12.65 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.4 | $36M | 872k | 41.65 | |
| Aquestive Therapeutics (AQST) | 0.4 | $35M | 6.3M | 5.59 | |
| Abivax Sa Sponsored Ads (ABVX) | 0.4 | $30M | 350k | 84.90 | |
| Ge Healthcare Technologies I Common Stock (GEHC) | 0.4 | $30M | 394k | 75.10 | |
| Replimune Group (REPL) | 0.3 | $27M | 6.4M | 4.19 | |
| Neurogene (NGNE) | 0.3 | $24M | 1.4M | 17.33 | |
| Belite Bio Sponsored Ads (BLTE) | 0.3 | $23M | 313k | 74.00 | |
| Alector (ALEC) | 0.3 | $21M | 7.0M | 2.96 | |
| Health Sciences Acq Corp 2 (OBIO) | 0.3 | $21M | 8.3M | 2.48 | |
| Corvus Pharmaceuticals (CRVS) | 0.2 | $20M | 2.7M | 7.37 | |
| Exagen (XGN) | 0.2 | $19M | 1.7M | 10.99 | |
| Heartflow Inc/Sh | 0.2 | $17M | 495k | 33.66 | |
| Tempus Ai Cl A (TEM) | 0.2 | $16M | 200k | 80.71 | |
| Jade Biosciences Com New (JBIO) | 0.2 | $13M | 1.4M | 8.63 | |
| Cytomx Therapeutics (CTMX) | 0.1 | $11M | 3.5M | 3.19 | |
| Cullinan Oncology (CGEM) | 0.1 | $10M | 1.7M | 5.93 | |
| Larimar Therapeutics (LRMR) | 0.1 | $10M | 3.1M | 3.23 | |
| Compass Therapeutics (CMPX) | 0.1 | $8.8M | 2.5M | 3.50 | |
| Perceptive Cap Solutions Cor Cl A Ord Shs (PCSC) | 0.1 | $7.8M | 743k | 10.56 | |
| Pepgen (PEPG) | 0.1 | $6.9M | 1.5M | 4.62 | |
| Wave Life Sciences SHS (WVE) | 0.1 | $6.6M | 900k | 7.32 | |
| Allurion Technologies Common Stock (ALUR) | 0.1 | $5.2M | 2.5M | 2.05 | |
| Milestone Pharmaceuticals (MIST) | 0.1 | $5.0M | 2.5M | 2.00 | |
| Omada Health (OMDA) | 0.1 | $4.4M | 200k | 22.11 | |
| Tenax Therapeutics Com New (TENX) | 0.0 | $2.9M | 378k | 7.61 | |
| Imagenebio | 0.0 | $2.7M | 334k | 8.15 | |
| Adagio Med Hldgs (ADGM) | 0.0 | $406k | 209k | 1.94 | |
| Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $14k | 350k | 0.04 |